|
1
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Pardo C and Cendales R: Incidencia
estimada y mortalidad por cancer en Colombia, 2002–2006. Instituto
Nacional de Cancerología; Legis S.A: 2010
|
|
3
|
Walboomers JM, Jacobs MV, Manos MM, Bosch
FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ and Muñoz N:
Human papillomavirus is a necessary cause of invasive cervical
cancer worldwide. J Pathol. 189:12–19. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Muñoz N: Human papillomavirus and cancer:
The epidemiological evidence. J Clin Virol. 19:1–5. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Blackburn EH: Structure and function of
telomeres. Nature. 350:569–573. 1991. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cohen SB, Graham ME, Lovrecz GO, Bache N,
Robinson PJ and Reddel RR: Protein composition of catalytically
active human telomerase from immortal cells. Science.
315:1850–1853. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Snijders PJ, van Duin M, Walboomers JM,
Steenbergen RD, Risse EK, Helmerhorst TJ, Verheijen RH and Meijer
CJ: Telomerase activity exclusively in cervical carcinomas and a
subset of cervical intraepithelial neoplasia grade III lesions:
Strong association with elevated messenger RNA levels of its
catalytic subunit and high-risk human papillomavirus DNA. Cancer
Res 58: 3812–3818, 1998. Cancer Res 58: 3812–3818, 1998. 58:
3812–3818, 1998:3812-3818, 1998–3818, 1998. 1998.
|
|
8
|
Shay JW and Wright WE: Senescence and
immortalization: Role of telomeres and telomerase. Carcinogenesis.
26:867–874. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Holt SE and Shay JW: Role of telomerase in
cellular proliferation and cancer. J Cell Physiol. 180:10–18. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ault KA, Allen HK, Phillips SL, Zimmerman
MB and Klingelhutz AJ: Telomerase activity as a potential
diagnostic marker for triage of abnormal Pap smears. J Low Genit
Tract Dis. 9:93–99. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sharma A, Rajappa M, Saxena A and Sharma
M: Telomerase activity as a tumor marker in Indian women with
cervical intraepithelial neoplasia and cervical cancer. Mol Diagn
Ther. 11:193–201. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu H, Liu S, Wang H, Xie X, Chen X, Zhang
X and Zhang Y: Genomic amplification of the human telomerase gene
(hTERC) associated with human papillomavirus is related to the
progression of uterine cervical dysplasia to invasive cancer. Diagn
Pathol. 7:1472012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Castro-Duque AF, Loango-Chamorro N,
Ruiz-Hoyos BM and Landázuri P: Telomerase activity associated with
progression of cervical lesions in a group of Colombian patients.
Rev Bras Ginecol Obstet. 37:559–564. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Pinto-Tang J, Castro T and Premoli G:
Detection of telomerase activity in cervical lesions by
non-radioactive telomeric repeat amplification protocol (TRAP).
Invest Clin. 46:255–263. 2005.(In Spanish). PubMed/NCBI
|
|
15
|
Kailash U, Soundararajan CC, Lakshmy R,
Arora R, Vivekanandhan S and Das BC: Telomerase activity as an
adjunct to high-risk human papillomavirus types 16 and 18 and
cytology screening in cervical cancer. Br J Cancer. 95:1250–1257.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Veldman T, Liu X, Yuan H and Schlegel R:
Human papillomavirus E6 and Myc proteins associate in vivo and bind
to and cooperatively activate the telomerase reverse transcriptase
promoter. Proc Natl Acad Sci USA. 100:pp. 8211–8216. 2003;
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Seo E Jeong, Kim H Jung, Jae Lee C, Tae
Kang H and Hwang E Seong: The role of HPV oncoproteins and cellular
factors in maintenance of hTERT expression in cervical carcinoma
cells. Gynecol Oncol. 94:40–47. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu X, Yuan H, Fu B, Disbrow GL,
Apolinario T, Tomaic V, Kelley ML, Baker CC, Huibregtse J and
Schlegel R: The E6AP ubiquitin ligase is required for
transactivation of the hTERT promoter by the human papillomavirus
E6 oncoprotein. J Biol Chem. 280:10807–10816. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Katzenellenbogen RA, Vliet-Gregg P, Xu M
and Galloway DA: NFX1-123 increases hTERT expression and telomerase
activity posttranscriptionally in human papillomavirus type 16 E6
keratinocytes. J Virol. 83:6446–6456. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhou Y, Xu F, Tao F, Feng D, Ling B, Qian
L, Yang X, Wang Q, Wang H, Zhao W, et al: GRIM-19 restores cervical
cancer cell senescence by repressing hTERT transcription. J
Interferon Cytokine Res. 36:506–515. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Koskimaa HM, Kurvinen K, Costa S, Syrjänen
K and Syrjänen S: Molecular markers implicating early malignant
events in cervical carcinogenesis. Cancer Epidemiol Biomarkers
Prev. 19:2003–2012. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li T, Tang L, Bian D, Jia Y, Huang X and
Zhang X: Detection of hTERC and c-MYC genes in cervical epithelial
exfoliated cells for cervical cancer screening. Int J Mol Med.
33:1289–1297. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhao XY, Cui Y, Jiang SF, Liu KJ, Han HQ,
Liu XS and Li Y: Human telomerase gene and high-risk human
papillomavirus infection are related to cervical intraepithelial
neoplasia. Asian Pac J Cancer Prev. 16:693–697. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Molano M, Posso H, Weiderpass E, van den
Brule AJ, Ronderos M, Franceschi S, Meijer CJ, Arslan A and Munoz
N; HPV Study Group HPV Study, : Prevalence and determinants of HPV
infection among Colombian women with normal cytology. Br J Cancer.
87:324–333. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
van den Brule AJ, Pol R,
Fransen-Daalmeijer N, Schouls LM, Meijer CJ and Snijders PJ:
GP5+/6+ PCR followed by reverse line blot analysis enables rapid
and high-throughput identification of human papillomavirus
genotypes. J Clin Microbiol. 40:779–787. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Castellsagué X and Muñoz N: Chapter 3:
Cofactors in human papillomavirus carcinogenesis-role of parity,
oral contraceptives, and tobacco smoking. J Natl Cancer Inst
Monogr. 1–28. 2003.PubMed/NCBI
|
|
27
|
Hamlin-Douglas LK, Coutlée F, Roger M,
Franco EL and Brassard P: Prevalence and age distribution of human
papillomavirus infection in a population of Inuit women in Nunavik,
Quebec. Cancer Epidemiol Biomarkers Prev. 17:3141–3149. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Berois N, Heard I, Fort Z, Alonso R, Sica
A, Moerzinger P, Rodriguez G, Sancho-Garnier H, Osinaga E and Favre
M: Prevalence of type-specific HPV infection in Uruguay. J Med
Virol. 86:647–652. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ogembo RK, Gona PN, Seymour AJ, Park HS,
Bain PA, Maranda L and Ogembo JG: Prevalence of human
papillomavirus genotypes among African women with normal cervical
cytology and neoplasia: A systematic review and meta-analysis. PLoS
One. 10:e01224882015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Muñoz N, Franceschi S, Bosetti C, Moreno
V, Herrero R, Smith JS, Shah KV, Meijer CJ and Bosch FX;
International Agency for Research on Cancer, ; Multicentric
Cervical Cancer Study Group, : Role of parity and human
papillomavirus in cervical cancer: The IARC multicentric
case-control study. Lancet. 359:1093–1101. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Almonte M, Albero G, Molano M, Carcamo C,
García PJ and Pérez G: Risk factors for human papillomavirus
exposure and co-factors for cervical cancer in Latin America and
the Caribbean. Vaccine. 26 Suppl 11:L16–L36. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Muñoz N, Hernandez-Suarez G, Méndez F,
Molano M, Posso H, Moreno V, Murillo R, Ronderos M, Meijer C and
Muñoz A; Instituto Nacional de Cancerología HPV Study Group, :
Persistence of HPV infection and risk of high-grade cervical
intraepithelial neoplasia in a cohort of Colombian women. Br J
Cancer. 100:1184–1190. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Roura E, Travier N, Waterboer T, de
Sanjosé S, Bosch FX, Pawlita M, Pala V, Weiderpass E, Margall N,
Dillner J, et al: Correction: The influence of hormonal factors on
the risk of developing cervical cancer and pre-cancer: Results from
the EPIC cohort. PLoS One. 11:e01514272016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Rosa MI, Medeiros LR, Bozzetti MC, Fachel
J, Wendland E, Zanini RR, Moraes AB and Rosa DD: Accuracy of
telomerase in cervical lesions: A systematic review. Int J Gynecol
Cancer. 17:1205–1214. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Klingelhutz AJ, Foster SA and McDougall
JK: Telomerase activation by the E6 gene product of human
papillomavirus type 16. Nature. 380:79–82. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Veldman T, Horikawa I, Barrett JC and
Schlegel R: Transcriptional activation of the telomerase hTERT gene
by human papillomavirus type 16 E6 oncoprotein. J Virol.
75:4467–4472. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Liu X, Roberts J, Dakic A, Zhang Y and
Schlegel R: HPV E7 contributes to the telomerase activity of
immortalized and tumorigenic cells and augments E6-induced hTERT
promoter function. Virology. 375:611–623. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Schütze DM, Kooter JM, Wilting SM, Meijer
CJ, Quint W, Snijders PJ and Steenbergen RD: Longitudinal
assessment of DNA methylation changes during HPVE6E7-induced
immortalization of primary keratinocytes. Epigenetics. 10:73–81.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Lee D, Kim HZ, Jeong KW, Shim YS, Horikawa
I, Barrett JC and Choe J: Human papillomavirus E2 down-regulates
the human telomerase reverse transcriptase promoter. J Biol Chem.
277:27748–27756. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kyo S, Takakura M, Fujiwara T and Inoue M:
Understanding and exploiting hTERT promoter regulation for
diagnosis and treatment of human cancers. Cancer Sci. 99:1528–1538.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
de Wilde J, Kooter JM, Overmeer RM,
Claassen-Kramer D, Meijer CJ, Snijders PJ and Steenbergen RD: hTERT
promoter activity and CpG methylation in HPV-induced
carcinogenesis. BMC Cancer. 10:2712010. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Jiang J, Zhao LJ, Zhao C, Zhang G, Zhao Y,
Li JR, Li XP and Wei LH: Hypomethylated CpG around the
transcription start site enables TERT expression and HPV16 E6
regulates TERT methylation in cervical cancer cells. Gynecol Oncol.
124:534–541. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Daniel M, Peek GW and Tollefsbol TO:
Regulation of the human catalytic subunit of telomerase (hTERT).
Gene. 498:135–146. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Molano M, Moreno-Acosta P, Morales N,
Burgos M, Buitrago L, Gamboa O, Alvarez R, Garland SM, Tabrizi SN,
Steenbergen RD and Mejía JC: Association between type-specific HPV
infections and hTERT DNA methylation in patients with invasive
cervical cancer. Cancer Genomics Proteomics. 13:483–491. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Ludlow AT, Zimmerman JB, Witkowski S,
Hearn JW, Hatfield BD and Roth SM: Relationship between physical
activity level, telomere length, and telomerase activity. Med Sci
Sports Exerc. 40:1764–1771. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Zhu H, Guo D, Li K, Pedersen-White J,
Stallmann-Jorgensen IS, Huang Y, Parikh S, Liu K and Dong Y:
Increased telomerase activity and vitamin D supplementation in
overweight African Americans. Int J Obes (Lond). 36:805–809. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Deng W, Cheung ST, Tsao SW, Wang XM and
Tiwari AF: Telomerase activity and its association with
psychological stress, mental disorders, lifestyle factors and
interventions: A systematic review. Psychoneuroendocrinology.
64:150–163. 2016. View Article : Google Scholar : PubMed/NCBI
|
